Michael Nathenson

Michael Nathenson has extensive work experience in the medical field. Michael currently serves as a Medical Director at Adaptimmune (since 2023). Prior to that, they held the same position at GSK (from 2021 to 2023). Before transitioning into a director role, they worked as a Clinical Instructor at the Dana-Farber Cancer Institute (from 2016 to 2021). Michael also has experience as a Sarcoma Medical Oncology Fellow at MD Anderson Cancer Center (from 2015 to 2016), and as a Hematology Oncology Fellow at the University of Maryland Medical Center (from 2012 to 2015). Their early experience includes being a Resident at UPMC (from 2009 to 2012).

Michael Nathenson attended Brandeis University for an unspecified period of time. Michael then went on to attend Tufts University School of Medicine, where they earned an MD degree. The start and end years for both institutions are not provided.